Dr. Marina is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
NA
La Jolla, CA 92037
Education & Training
- Stanford UniversityMS, epidemiology, 2010 - 2011
- Stanford UniversityMS, Epidemiology, Magna Cum Laude, 2011
- University of TennesseeFellowship, Pediatric Hematology/Oncology, 1986 - 1989
- University of Puerto RicoResidency, Pediatrics, 1983 - 1986
- University of Puerto Rico School of MedicineClass of 1983
- University of Puerto RicoBS, Chemistry, 1979
Certifications & Licensure
- CA State Medical License 1995 - 2024
- TN State Medical License 1986 - 1995
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors for Cancer Castle Connolly, 2005-2013, 2016
- America's Top Doctors Castle Connolly, 2009-2014, 2016
- Alpha Omega Alpha 1982
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- 55 citationsBemarituzumab with modified FOLFOX6 for advanced FGFR2-positive gastroesophageal cancer: FIGHT Phase III study design.Daniel V.T. Catenacci, Anteneh Tesfaye, Mohamed Tejani, Eric Cheung, Peter D. Eisenberg
Future Oncology. 2019-05-16 - 2441 citationsChronic Health Conditions in Adult Survivors of Childhood CancerKevin C. Oeffinger, Ann C. Mertens, Charles A. Sklar, Toana Kawashima, Melissa M. Hudson
The New England Journal of Medicine. 2006-10-12 - 210 citationsMonitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.Sadhna M. Shankar, Neyssa Marina, Melissa M. Hudson, David C. Hodgson, M. Jacob Adams
Pediatrics. 2008-02-01
Journal Articles
- Identification of discrete prognostic groups in Ewing sarcomaKarski EE, McIlvain E, Segal MR, Krailo M, Grier HE, Granowetter L, Womer RN, Meyers PA, Felgenhauer J, Marina N, DuBois SG., Pediatr Blood Cancer, 1/1/2016
- Pilot Study of Adding Vincristine, Topotecan and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly diagnosed patients with localized Ewing Sarcoma: A Repor...Mascarenhas L, Felgenhauer JL, Bond MC, Villaluna D, Femino JD, Laack NN, Ranganathan S, Meyer J, Womer RB, Gorlick R, Krailo MD, Marina N., Pediatr Blood Cancer, 1/1/2016
- Assessment of extent of surgical resection of primary high-grade osteosarcoma by treating institutions: A report from the Children’s Oncology GroupMorris CD, Teot LA, Bernstein ML, Marina N, Krailo MD, Villaluna D, Janeway KA, DuBois SG, Gorlick RG, Randall RL, J Surg Oncol, 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Prognostic factors in children with extragonadal germ cell tumors (GCT): A Pediatric Intergroup Study.Marina N, London W, Lauer S, Giller R, Rescorla F, Cushing B, Vinocur C, Malogolowkin M, Castleberry R, Womer R, Med Pediatr Oncol, 1/1/2000
- Results of surgery alone or surgery plus cisplatin, etoposide and bleomycin (PEB) in children with localized gonadal malignant germ cell tumors (MGCT): a pediatric Int...Cushing B, Giller R, Marina N, Lauer S, Green A, Cullen J, Ablin A, Weetman R, Vinocur C, Rescorla F, Hawkins E, Heifetz S, Rao PV, Krailo M, Castleberry RP, Proc Am Soc Clin Oncol, 1/1/1997
- Join now to see all
Lectures
- Update on the Management of Children, Adolescents and Young Adults with Osteosarcoma1/1/2011
- The Children’s Oncology Group Experience with Dexrazoxane in Pediatric Sarcomas.1/1/2009
- Treatment Strategies for Osteosarcoma in the Children’s Oncology Group.1/1/2007
- Join now to see all
Press Mentions
- Additional Chemotherapy May Not Improve Bone Cancer OutcomeAugust 26th, 2016
Professional Memberships
- Member
- Member
- Member
- Connective Tissue Oncology SocietyMember
- American Society of Pediatric Hematology/OncologyMember
Other Languages
- Spanish
Industry Relationships
- Senior Medical Director, Arcus Bioscienced2023 - Present
- Clinical Lead, Early Oncology Development, Sanofi2021 - 2023
- Executive Medical Director, Synthorx A Sanofi Company2020 - 2020
- Executive Medical Directot, Synthorx2019 - 2020
- Director, Clinical Development, Five Prime Therapeutics2017 - 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: